Keyphrases
Survival Benefit
100%
Liver Tumor
100%
Monoclonal Antibody
100%
Tumor Xenograft Model
100%
Cadherin-17
100%
Cisplatin
80%
Epirubicin
80%
Hepatocellular Carcinoma
40%
Therapeutic Agents
40%
Tumor-bearing nude Mice
40%
Complementarity-determining Region 3 (CDR3)
40%
Orthotopic Tumor
40%
Breast Cancer
20%
Hepatocellular Carcinoma Cells
20%
Antitumor
20%
Growth Inhibition
20%
Mouse Xenograft Model
20%
Tumor
20%
Liver Cancer
20%
Tumor Inhibition
20%
Humanized
20%
Lung Cancer
20%
Hepatoma Xenograft
20%
Improved Survival
20%
Xenograft Model
20%
Orthotopic Hepatocellular Carcinoma
20%
Heavy Chain
20%
Subcutaneous Tumor
20%
Cell Proliferation Assay
20%
Light Chain
20%
Orthotopic Tumor Xenograft
20%
Sensitizing Effect
20%
Animal Survival
20%
Antibody Humanization
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Liver Tumor
100%
Monoclonal Antibody
100%
Cadherin
100%
Cisplatin
66%
Liver Cell Carcinoma
66%
Epirubicin
66%
Nude Mouse
33%
Mouse Model
16%
Breast Cancer
16%
Lung Cancer
16%
Cancer Inhibition
16%
Liver Cancer
16%
Immunology and Microbiology
Xenograft
100%
Monoclonal Antibody
100%
Cadherin
100%
Nude Mouse
40%
Growth Inhibition
40%
Complementarity Determining Region
40%
Carcinoma Cell
20%
Cell Proliferation
20%
Mouse Model
20%
Light Chain
20%
Heavy Chain
20%